|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12N 5/02 | |
| C12N 5/16 |
| (11) | Patento numeris | 3055409 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14851841.8 |
| Europos patento paraiškos padavimo data | 2014-10-10 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-08-17 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-04-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/059993 |
| Data | 2014-10-10 |
| (87) | Numeris | WO 2015/054554 |
| Data | 2015-04-16 |
| (30) | Numeris | Data | Šalis |
| 201361889815 P | 2013-10-11 | US |
| (72) |
LAWRENCE, Shawn, US
KIM, Ann, US
JOHNSON, Amy, US
|
| (73) |
Regeneron Pharmaceuticals, Inc.,
777 Old Saw Mill River Road, Tarrytown, NY 10591,
US
|
| (54) | METABOLICALLY OPTIMIZED CELL CULTURE |
| METABOLICALLY OPTIMIZED CELL CULTURE |